Arteris, Inc. AIP
Semiconductors · IPO 2021 · data as of November 13, 2026
Arteris, Inc. (AIP) is a technology company listed in the US with a market value of about $962M. In the twelve months to September 30, 2026 it had revenue of $93M and net income of -$42M, a net margin of -44.8%.
Its overall Stock Analiz score is 1.8 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: a price to free cash flow of 443.7, 5-year revenue growth of 17% a year, a 5-year average ROIC of -290%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 93% below the current price.
About Arteris
Arteris is listed in the US and classified in semiconductors, IPO year 2021. Revenue went from $32M in 2020 to $71M in 2025, growth of about 17.3% a year. It was profitable in 0 of the last 6 years in our data. Its share count rose by 30% over three years (dilution for shareholders). It spends 71% of revenue on research and development.
Score: 1.8 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- ROE above 15%
- More cash than debt, or low debt to equity
- Positive free cash flow
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $93M | $71M | $58M | $54M | $50M | $38M | $32M |
| Net income | -$42M | -$35M | -$34M | -$37M | -$27M | -$23M | -$3M |
| Free cash flow | $2M | $5M | -$1M | -$17M | -$8M | -$2M | $2M |
| EPS (diluted) | $-0.89 | $-0.82 | $-0.86 | $-1.03 | $-0.84 | $-1.06 | $-0.19 |
| Net margin | -44.8% | -49.2% | -58.3% | -68.7% | -54.4% | -61.8% | -10.2% |
| ROIC | — | — | -915.3% | -142.4% | -72.1% | -30.9% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 7 analysts is $33.00, 71% above the current price; targets range from $25.00 to $40.00; the consensus rating is “Strong buy”; expected EPS is $-0.14 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Arteris stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 93% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Arteris pay a dividend?
Not currently.
Is Arteris a good stock to buy?
We do not give buy or sell advice. Arteris scores 1.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.